Patients with platelet count <20 × 109/L who received drug therapy (including platelet transfusions)
| No. of bleeding sites reported since last research visit . | Drug treatment reported . | ||
|---|---|---|---|
| Between 28 d and 6 mo (%), n = 61* . | Between 6 and 12 mo (%), n = 50† . | Between 12 and 24 mo (%), n = 17‡ . | |
| None | 0/1 (0) | 3/12 (25) | 0/3 (0) |
| 1 | 19/25 (76) | 11/18 (61) | 5/6 (83) |
| ≥2 | 33/35 (94) | 15/20 (75) | 6/8 (75) |
| No. of bleeding sites reported since last research visit . | Drug treatment reported . | ||
|---|---|---|---|
| Between 28 d and 6 mo (%), n = 61* . | Between 6 and 12 mo (%), n = 50† . | Between 12 and 24 mo (%), n = 17‡ . | |
| None | 0/1 (0) | 3/12 (25) | 0/3 (0) |
| 1 | 19/25 (76) | 11/18 (61) | 5/6 (83) |
| ≥2 | 33/35 (94) | 15/20 (75) | 6/8 (75) |